Company Filing History:
3 out of 245 
1 out of 3 Years Active: 2009-2017
Title: Susan Engelbrecht: Innovator in HIV Research
Introduction
Susan Engelbrecht is a prominent inventor based in Tygerberg, South Africa. She has made significant contributions to the field of HIV research, particularly in the development of immunogenic polypeptides. With a total of 3 patents, her work has the potential to impact the future of HIV treatment and prevention.
Latest Patents
Engelbrecht's latest patents include innovative approaches to HIV-1 South African subtype C env proteins. The first patent describes polynucleotides encoding immunogenic HIV polypeptides, detailing their uses in immunization, generation of packaging cell lines, and production of HIV polypeptides. The second patent focuses on expression cassettes encoding modified HIV-1 South African subtype C Env polypeptides, which include deletions in the V1 and V2 regions. This invention also outlines a recombinant expression system for use in selected host cells.
Career Highlights
Throughout her career, Engelbrecht has worked with notable organizations such as Novartis Vaccines & Diagnostics and the University of Stellenbosch. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Engelbrecht's coworkers include Jan Zur Megede and Susan Barnett. Their collaborative efforts have further advanced the research and development of HIV-related innovations.
Conclusion
Susan Engelbrecht's work in HIV research exemplifies the importance of innovation in addressing global health challenges. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.